Negative-pressure Wound Therapy (NPWT) Devices Market Outlook 2031
- The global negative-pressure wound therapy (NPWT) devices market was valued at US$ 3.4 Bn in 2021
- The global market is projected to grow at a CAGR of 6.0% from 2022 to 2031
- The global negative-pressure wound therapy (NPWT) devices market is anticipated to reach more than US$ 6 Bn by the end of 2031
Get Sample Copy of the Report@
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1718
Negative-pressure Wound Therapy (NPWT) Devices Market Introduction
Negative-pressure wound therapy (NPWT), also known as vacuum-assisted wound closure, refers to wound dressing systems that continuously or intermittently apply sub-atmospheric pressure to the system, creating positive pressure on the surface of a wound. Negative-pressure therapy technology has gained popularity as a management technique for various acute and chronic wounds or surgical wounds. Benefits of negative-pressure wound therapy include faster wound granulation and re-epithelialization, reduction of bacterial load, and increased tissue oxygenation. Rise in adoption of advanced NPWT systems, which include open-pore foam sponge, adhesive dressing, and vacuum pump, is driving the global market. Additionally, negative-pressure wound therapy technology provides advantages such as better healing of transplanted skin and shorter hospital stay for patients receiving split-thickness skin grafts. Recent improvements in negative-pressure wound therapy (NPWT) devices, such as increased accuracy and efficiency in smart pressure portable NPWT devices, has led to an increase in demand for these devices. In developed countries, demand for NPWT devices is increasing in homecare settings due to safety features, easy handling, and high awareness about the devices.
Rise in Prevalence of Chronic & Acute Injuries to Drive Global Negative-pressure Wound Therapy (NPWT) Devices Market
The burden of chronic and acute injuries across the globe is expected to rise significantly in the next few years. According to the National Center for Biotechnology Information, more than 2.5 million people in the U.S. develop pressure ulcers each year. According to the National Health Service (NHS), over 700,000 patients in the U.K. are affected by pressure ulcers each year, and 180 000 of those are newly acquired each year. Diabetic foot ulcer is another major indication of negative-pressure wound therapy (NPWT) devices. Increase in number of patients suffering from diabetic foot ulcers is likely to drive the market during the forecast period.
Read Report Overview@ https://www.transparencymarketresearch.com/negative-pressure-wound-therapy.html
According to the National Center for Biotechnology Information, the annual incidence of diabetic foot ulcers globally is between 9.1 million and 26.1 million. Around 15% to 25% of patients with diabetes mellitus develop diabetic foot ulcer during their lifetime. The geriatric population is more prone to chronic & acute injuries and diabetic foot ulcers. Surge in geriatric population in developed as well as developing countries is likely to propel the negative-pressure wound therapy (NPWT) devices market during the forecast period.
Better Management of Severe Wound Exudates and Reduction in Overall Treatment Cost to Boost Demand for Conventional NPWT Devices
In terms of product type, the conventional NPWT devices segment accounted for major market share in 2021. Conventional NPWT devices consist of a filler (such as foam or gauze) that covers the wound and a permeable membrane and tubing that connects the space under the membrane to a suction pump. Significant share of the conventional NPWT devices segment can be ascribed to better management of severe wound exudates by portable conventional NPWT systems and reduction in overall treatment cost due to a decrease in the length of stay. Additionally, increase in demand for negative-pressure wound therapy devices due to inclination toward minimally invasive procedures is a key factor anticipated to drive the segment during the forecast period.
Enquiry Before Buying @
https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=1718
Increase in Prevalence of Diabetic Foot Ulcer Propelling Demand for NPWT Devices
Application of negative-pressure wound therapy devices include diabetic foot ulcers, pressure ulcers, venous leg ulcers, burn wounds, and surgical wounds. Based on application, the diabetic foot ulcer segment held significant share of the global negative-pressure wound therapy (NPWT) devices market in 2021. Rise in prevalence of diabetic foot ulcers is likely to increase the demand for negative-pressure wound therapy (NPWT) devices. Diabetic foot ulcer is an open sore or wound that typically develops on the bottom of the foot, and affects 15% of people with diabetes. Six percent of people who get foot ulcers end up in the hospital because of an infection or another problem related to the ulcer.
Growth in Rate of Hospitalization for Acute and Chronic Injuries to Augment Hospitals & Clinics Segment
In terms of end-user, the hospitals & clinics segment is likely to account for major share of the global negative-pressure wound therapy (NPWT) devices market during the forecast period. Growth of the segment can be ascribed to factors such as increase in rate of hospitalization for acute and chronic injuries and wide range of services offered by hospitals at a single site. The specialty clinics segment is driven by the increase in number of clinics across the globe along with rise in change in patient preference to be treated by specialists.
Get Report Methodology @
https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=1718
Regional Outlook of Global Negative-pressure Wound Therapy (NPWT) Devices Market
North America held the largest share of around 39% of the global negative-pressure wound therapy (NPWT) devices market in 2021. The region is expected to be a highly lucrative market during the forecast period, with a high market attractiveness index. This can primarily be ascribed to rise in prevalence of diabetic foot ulcers, pressure ulcers, and surgical wounds along with the growth in geriatric population in the region. The U.S. dominated the market in North America in 2021 owing to factors such as high patient pool for major chronic diseases, cardiovascular diseases, and large number of patients receiving negative-pressure wound therapy (NPWT) for acute & chronic injuries. Additionally, presence of key players, early adoption of technologically advanced products, and increase in research & development activities are projected to drive the market in the region.
Asia Pacific is anticipated to be the fastest-growing market for NPWT devices during the forecast period. The market in the region is anticipated to grow at a high CAGR during the forecast period due to the rise in demand for negative-pressure wound therapy (NPWT) devices. Rise in geriatric population and increase in number of people with diabetes & obesity are the key factors expected to propel the market in the region.
Get Custom Research Report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=1718
Analysis of Key Players in Global Negative-Pressure Wound Therapy (NPWT) Devices Market
The global negative-pressure wound therapy (NPWT) devices market is consolidated, with the presence of a small number of leading players. Expansion of product portfolio and mergers & acquisitions are the prominent strategies adopted by the key players in the global negative-pressure wound therapy (NPWT) devices market. Smith+Nephew, KCI (ACELITY), Cardinal Health, PAUL HARTMANN, ConvaTec, Inc., DeRoyal, Genadyne Biotechnologies, Inc., Medela, Inc. ATMOS MedizinTechnik GmbH & Co. KG, Talley Group Ltd., and Lohmann & Rauscher are key the players operating in the global negative-pressure wound therapy (NPWT) devices market.
About Us
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: [email protected]
Transparency Market Research (TMR) has published a new report titled, “Global Negative-pressure wound therapy devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.
Moreover, the high cost of negative-pressure technique is a major factor restraining the market.
Emerging technologies in portable negative-pressure wound therapy devices to propel marketEmerging technologies in negative-pressure wound therapy devices are projected to boost the global negative-pressure wound therapy devices market during the forecast period.
NPWT may decrease tissue oxygenation in the wound bed because the foam sponge of NPWT compresses the wound bed under the influence of the applied negative-pressure.
In the U.S., significant increase in prevalence of acute and chronic injuries is likely to propel the share held by the region in the global market during the forecast period.
These include SMITH AND NEPHEW, KCI (ACELITY), Cardinal Health, PAUL HARTMANN, ConvaTec Inc., DeRoyal, Genadyne Biotechnologies, Inc., Medela, Inc. ATMOS MedizinTechnik GmbH & Co. KG, Talley Group Ltd, and Lohmann & Rauscher.
